Increasing blood supply safety is one of the most important goals of blood services in the world. In this study, we reviewed the prevalence rate and the trends of three main infections in whole blood donations and strategies for improving blood safety in Yazd blood transfusion center, Iran.
Introduction
Prevalence evaluation of blood borne infections in blood donors is useful to assess blood safety. Blood transfusion centers are an important part of National Health Care system and their goal is to maintain adequate healthy and easily available blood components. Several methods have been used to increase blood safety: society and blood donors' educational programs, adoption of better donor selection criteria, improvement of more sensitive and specific laboratory tests to detect Hepatitis B virus (HBV), Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) in donated blood (1) (2) (3) (4) (5) . The prevalence of blood borne infections has been evaluated in many world regions and resulted in different rates. These differences are because of variation in the prevalence rate in general population, types of donation (voluntary or replacement), screening methods and laboratory tests in different societies (6) (7) (8) . In Iran, changes in prevalence of blood borne infections had been previously studied (9) (10) (11) (12) . In this study we evaluated the trends of HBV, HCV and HIV infections in blood donors in correlation with demographic data and blood donor's status (first-time, lapsed and regular donors) from 2004 to 2010 in Yazd province.
Materials and Methods
In this descriptive and analytical study, retrospective review of donor's record covering the period during 2004 -2010 at Yazd blood transfusion center was carried out. Data on donation numbers, donation status, demographic characteristics and screening and confirmatory test results of HBV, HCV and HIV were obtained from the Iranian Blood Services National Epidemiology Donor Database. The donations were all screened for HBs-Ag, anti-HIV, HIV antigen/antibody (from 2005), anti-HCV according to standard operating procedures by approved commercial kits (10) . Confirmatory tests included the monoclonal neutralization assay for HBs-Ag, the third-generation recombinant immunoblot assay (RIBA 3.0) for HCV and HIV-I/II Western blot (WB) assay for HIV infection (10) . Donors between 18 and 65 years were selected through vital sign examinations, anemia screening and medical history and risk behavior interviews, which are routinely performed by trained physicians. A first-time blood donor was identified as a donor who donated for the first time. A regular donor was defined as a donor who donated more than once during one year and a lapsed donor was any donor who had a history of previous donation, but the interval between two donations was more than one year. Before blood donation, a consent form was signed by all blood donors.
Statistical Analysis
Frequency of HBs-Ag, HIV antigen/antibody, anti-HCV antibody per 100,000 donations and 95% confidence interval (CI) were calculated using a binomial distribution. The prevalence rate of infections was calculated in each demographic group, and compared using chi-square test and considered significant if p-value was less than 0.05.
Results
In total, according to the database records, there were 254760 allogenic whole blood donations during 2004 to 2010 at Yazd blood transfusion service. Among whom ninety six percent (96%) were male and four percent were female. 33% were first time, 26% were lapsed and 41% were regular donors. (Fig 1) .According to age, the 30-39 age group was the most prevalent group for HCV-Ab (P-value= 0.014). HCV-Ab positive donations were significantly more prevalent in BSc and BA and high school groups (P-value< 0.001) ( Table I ). The trend of HCV-Ab positive rate due to blood donor's status was decreasing (Fig 3) . HCV-Ab prevalence rate was 205, 72 and 21 per10 
Discussion
The study results showed that transfusion-transmissible infections (TTIs) had a decreasing trend during 2004 to 2010 (Fig 1) . This trend is more dramatic for HBs-Ag In Yazd blood transfusion center, some strategies that are used to increase blood supply safety are: The act of donor counseling and donor selection performed by trained physicians, Regular counseling educational workshops are provided for them , Integrated software is used for donor registry and donor selection in all donor centers including mobile teams in the province, Surveillance of TTI markers in mobile teams' donations is performed, Those regions with high prevalence of positive markers are omitted, Increasing in regular blood donor rates by persuading healthy first time and lapsed donors to donate blood regularly at least two times a year, Detecting people who would like to donate blood only to be tested for TTIs and referring them to health care centers where they would be tested for free, Implementing confidential unit exclusion program in blood centers and more awareness of donors about transmission routes and self -avoidance of blood donation in the case of high-risk behaviors. Lower frequency of viral infections in regular donors than lapsed and first time donors could be due to more awareness in this group or elimination of donors with initial reactive screening tests. The decreasing slope for HCV-Ab was slower than HBs-Ag. The HBs-Ag prevalence rate in first -time donors has been increased in the last two years (2009-2010). Probably it is the result of increase in infection prevalence in general population. This is similar to studies performed in Kuwait, France and The USA (3, 4, and 13) . In the study's period, the prevalence of HBs-Ag was significantly more in females (P-value= 0.002). Analysis showed that first-time donations were significantly more in females and it could be cause of higher prevalence of HBs-Ag in this group (P-value< 0.001). However, according to studies in the USA, France and Shiraz (Iran), the prevalence of both HBsAg and HCV-Ab was more in males than females (3, 4, 9) . In lapsed and regular donors, the rate of HBs-Ag was zero in the last two years that shows more accuracy in donor selection and more education of donors.
Due to age classification, below 20 year-old and between 40 to 49 year-old groups were the most prevalent groups for HBs-Ag (P-value< 0.001). In Kuwait, below 39 year-old, in France between 40 to 49 year-old and in Saudi Arabia above 50 year-old groups were more prone to hepatitis B (3, 13, and 14) . The prevalence rate of HCV-Ab due to donation status had decreasing trend during study's period. There was a significant difference between HCV-Ab prevalence rate among regular, first -time and lapsed donors. The prevalence rate among first -time donors was three times higher than lapsed and 10.5 times higher than regular donors that is almost similar to Kuwait, the USA, France and Shiraz (Iran) (3, 4, 9, 13) . The frequency of HCV-Ab among donors with different gender and marital status did not have any significant difference. In the USA and Shiraz (Iran), it was higher in males (4, 9) . In Saudi Arabia and France, there were not any significant difference between males and females (3, 14) .The 30-39 yearold group was the most prevalent group for HCV infection in our study. This result is similar to study of Amini et al but there were significant associations between increasing age and HCV in a study in Brazil (2, 12) . The prevalence rate of HCV was higher in below 39-year-old group in Kuwait (13) . The prevalence rate of HIV in general population in Iran was 0.008 and 0.023 percent in years 1999 and 2007, respectively. Despite increase in prevalence rate of HIV infection in general population, the prevalence rate in whole blood donations did not increased during the study period. In this study, the prevalence rate of TTIs was less than neighbor countries such as Pakistan and Turkey (15) (16) (17) .
Conclusion
Totally, lower prevalence rate of TTIs in blood donors and its decreasing trends shows that the safety procedures performed at Yazd blood transfusion organization during these years were efficient. However, these rates could be more under control by using implementation of nucleic acid test (NAT) for detection of HBV, HCV and HIV in blood donations and education of society about routes and risk factors for transmission of TTIs, high-risk behaviors and the importance of blood donation by healthy donors.
